Evidence map›Paper›PMID 41039157›Full record

ArticleThe EMBO journal2025

RNF114 and RNF166 exemplify reader-writer E3 ligases that extend K11 polyubiquitin onto sites of MARUbylation.

Rachel E Lacoursiere, Kapil Upadhyaya, Jasleen Kaur Sidhu, Ivan Rodriguez Siordia, Daniel S Bejan, Michael S Cohen, Jonathan N Pruneda

Abstract read
In one paragraph

Article in The EMBO journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Rachel E Lacoursiere *Department of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, OR, 97239, USA.ORCID http://orcid.org/0000-0002-3405-2170
Kapil Upadhyaya *Department of Chemical Physiology and Biochemistry, Oregon Health & Science University, Portland, OR, 97239, USA.ORCID http://orcid.org/0000-0001-9083-7784
Jasleen Kaur SidhuDepartment of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, OR, 97239, USA.ORCID http://orcid.org/0000-0001-5010-042X
Ivan Rodriguez SiordiaDepartment of Chemical Physiology and Biochemistry, Oregon Health & Science University, Portland, OR, 97239, USA.
Daniel S BejanDepartment of Chemical Physiology and Biochemistry, Oregon Health & Science University, Portland, OR, 97239, USA.ORCID http://orcid.org/0000-0002-5090-0299
Michael S CohenDepartment of Chemical Physiology and Biochemistry, Oregon Health & Science University, Portland, OR, 97239, USA. cohenmic@ohsu.edu.ORCID http://orcid.org/0000-0002-7636-4156
Jonathan N PrunedaDepartment of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, OR, 97239, USA. pruneda@ohsu.edu.ORCID http://orcid.org/0000-0002-0304-4418

Funding

Understanding the origins of rapid recurrence of pancreatic cancer after resectionP30CA069533 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI Luiz Eduardo Bertassoni · 1997 to 2026
$60.5M
Proteomics CoreP30EY010572 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI John Peter Campbell · 1995 to 2026
$19.4M
Decoding protein MARylation networks in astrocytes using chemical biology approachesR01NS088629 · NINDS · OREGON HEALTH & SCIENCE UNIVERSITY · PI COHEN, MICHAEL S · 2014 to 2024
$4.2M
Program in Biomedical SciencesT32GM142619 · NIGMS · OREGON HEALTH & SCIENCE UNIVERSITY · PI Jeffrey Wallace Tyner · 2021 to 2026
$3.2M
Exploiting bacterial effector proteins to study human ubiquitin signalingR35GM142486 · NIGMS · OREGON HEALTH & SCIENCE UNIVERSITY · PI Jonathan N Pruneda · 2021 to 2026
$2.6M
LTQ XL Linear Ion Trap Mass SpectrometerS10RR025571 · NCRR · OREGON HEALTH & SCIENCE UNIVERSITY · PI DAVID, LARRY L · 2009 to 2009
$389k
HHS | NIH | National Cancer Institute (NCI) P30CA069533HHS | NIH | National Center for Research Resources (NCRR) S10RR025571HHS | NIH | National Eye Institute (NEI) P30EY010572HHS | NIH | National Institute of General Medical Sciences (NIGMS) 1T32GM142619HHS | NIH | National Institute of General Medical Sciences (NIGMS) R35GM142486HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS) 2R01NS088629NCI NIH HHS P30 CA069533NCRR NIH HHS S10 RR025571NEI NIH HHS P30 EY010572NIGMS NIH HHS R35 GM142486NIGMS NIH HHS T32 GM142619NINDS NIH HHS R01 NS088629
6 · The paper itself

Abstract

Ubiquitin (Ub) cooperates with other post-translational modifications to provide a tiered opportunity for protein regulation. Deltex E3 ligases were previously implicated in ubiquitylation of ADP-ribose (ADPr)-containing macromolecules in vitro, generating a noncanonical mono-ADPr-Ub ester (MARUbe). We previously identified mono-ADPr ubiquitylation (MARUbylation) on PARP7 in cells, which was extended with K11-linked polyUb, suggesting an intricately regulated, multilayered post-translational modification. Here, we show that the Deltex DTX2 ubiquitylates ADPr modifications on PARP7 in cells, which depends on PARP7 catalytic activity. We further identify RNF114 as the E3 ligase responsible for K11-linked polyUb extension on sites of PARP7 MARUbylation. Using a chemoenzymatic approach, we developed a fluorescent Ub-ADPr probe and find that RNF114 explicitly recognizes MARUbylated species. We used AlphaFold3 to examine the mechanisms of Ub-ADPr recognition and K11-linked polyUb extension by RNF114. We identify a tandem Di19-UIM module in RNF114 as a MARUbe-binding domain (M-UBD), thus providing a reader function that interfaces with K11-specific writer activity. Finally, we describe a small family of M-UBD-containing E3 ligases that demonstrate preference for Ub-ADPr, which we call MARUbe-Targeted Ligases (M-UTLs).

Indexed as

PolyubiquitinUbiquitin-Protein LigasesAdenosine Diphosphate RiboseHEK293 CellsHumansPoly(ADP-ribose) PolymerasesProtein Processing, Post-TranslationalUbiquitinationAdenosine Diphosphate RibosePoly(ADP-ribose) PolymerasesPolyubiquitinUbiquitin-Protein LigasesADP-ribose UbiquitylationK11 PolyubiquitylationPARP/Ubiquitin CrosstalkPost-translational Modifications

Identifiers

PMID41039157
PMCPMC12583694

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.